Redhill Biopharma Ltd. (RDHL) Financials

RDHL Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 35.0 million 31.6 million
2023-03-31 158.9 million 207.3 million
2022-12-31 158.9 million 207.3 million
2022-09-30 157.2 million 203.2 million

RDHL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -10.6 million 705000
2023-03-31 -2.4 million 1.1 million
2022-12-31 -2.4 million 1.1 million
2022-09-30 -6.1 million 1.6 million

RDHL Net Income

No data available :(

RDHL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 7.0 million - 2.3 million
2023-03-31 20.0 million - 7.0 million
2022-12-31 20.0 million - 7.5 million
2022-09-30 15.2 million - 7.0 million

RDHL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 3.9 million
2023-03-31 1.5 million
2022-12-31 1.5 million
2022-09-30 1.6 million

RDHL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 7000 1.2 million 3.5 million 4.5 million
2023-03-31 1335 1.1 million 32.9 million -19.9 million
2022-12-31 - 1.1 million 32.9 million 19.9 million
2022-09-30 22000 1.6 million 6.5 million 7.1 million

RDHL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 1.8 million 806000
2023-03-31 12.8 million 8.6 million
2022-12-31 12.8 million 8.6 million
2022-09-30 17.6 million 9.5 million

RDHL

Price: $0.46

52 week price:
0.26
3.28

Earnings Per Share: 4.00 USD

P/E Ratio: -0.07

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 100.7 million

Ebitda: -13.8 million

Market Capitalization: 14.4 million

Links: